1. Market Research
  2. > Healthcare Market Trends
  3. > CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam”. It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Vietnam, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market, using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.

In 2015, Vietnam’s population stood at 92 million, an increase from 85 million in 2008 due to the high birth rate and low mortality rate. The country’s pharmaceutical market was estimated to have been worth $3.5 billion in 2015 and is expected to reach $6.6 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 13.8%. The medical device market was estimated at approximately $295m in 2015 and is expected to grow at a CAGR of 11.3% to $505m by 2020.

The positive trends in Vietnam’s healthcare market can primarily be attributed to -
- Increasing coverage of healthcare insurance
- Government initiatives to improve healthcare facilities

Scope

The report includes -
- Overview of the pharmaceutical and medical device markets, including size, segmentation and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, Hau Giang Pharmaceuticals (DHG Pharmaceuticals), Imexpharm, Traphaco and Domesco.
- An insightful review of the reimbursement and regulatory landscape, covering the healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices.
- Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

The report will enhance your decision-making capability by allowing you to -
- Develop business strategies through an understanding of the trends shaping and driving the healthcare market
- Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment and strategic partnership
- Identify, understand and capitalize on the opportunities and challenges in the healthcare market

Table Of Contents

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam
1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 16
2.1 GlobalData Report Guidance 16
3 Overview of the Pharmaceutical and Medical Device Markets 17
3.1 Pharmaceutical Market 17
3.1.1 Market Overview 17
3.1.2 Pharmaceutical Exports and Imports 19
3.1.3 Supply Channels 20
3.1.4 Market Segments 21
3.1.5 Major Disease Areas 24
3.1.6 Major Companies 27
3.2 Medical Device Market 45
3.3 Market Drivers and Barriers 47
3.3.1 Drivers 47
3.3.2 Barriers 47
4 Market Access 49
4.1 Reimbursement and Payer Landscape 49
4.1.1 Overview of Healthcare System 49
4.1.2 Reimbursement Process 50
4.1.3 Overview of Insurance Providers 51
4.1.4 Patient Share in Healthcare Spending 54
4.1.5 Price Trends in Healthcare Sector 54
4.1.6 Pricing Policies 55
4.2 Regulatory Landscape 56
4.2.1 Overview of Regulatory Agencies 56
4.2.2 Market Authorization Procedure for Pharmaceutical Products 57
4.2.3 New Medical Device Approval Process 62
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 64
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 65
4.2.6 Intellectual Property Rights 67
4.2.7 Clinical Trial Regulations 71
4.2.8 Pharmaceutical Advertising Regulations 72
4.2.9 Pharmacy Regulations 74
4.2.10 Labeling and Packaging Regulations 75
5 Country Analysis 78
5.1 Political Environment 78
5.1.1 Political Structure 78
5.1.2 Analysis of the Current Political Environment 78
5.1.3 Healthcare Policy Initiatives 79
5.2 Economic Landscape 81
5.3 Economic Indicators 83
5.3.1 Gross Domestic Product 83
5.3.2 Gross National Income 87
5.3.3 Inflation 88
5.3.4 Currency Exchange Rate 91
5.3.5 Foreign Direct Investment 92
5.3.6 Foreign Exchange Reserves 93
5.3.7 Trade Balance 94
5.3.8 General Government Structural Balance 96
5.3.9 General Government Net Debt 97
5.3.10 Major Industries 99
5.4 Demographics 100
5.4.1 Population 100
5.4.2 Education and Literacy 115
5.4.3 Employment 116
5.4.4 Disease Burden 117
5.5 Healthcare Infrastructure 119
5.5.1 Healthcare Facilities 119
5.5.2 Healthcare Parameters 122
5.5.3 Environmental Health 124
5.5.4 Healthcare Personnel 126
5.6 Healthcare Expenditure 129
5.6.1 Overview 129
5.6.2 Major Components of Healthcare Spending 130
5.6.3 Public and Private Sector Share 131
5.6.4 Spending in Healthcare RandD 131
5.7 Trade Associations 132
5.7.1 Vietnam Pharmaceutical Companies Association 132
5.7.2 Vietnam General Association of Medicine and Pharmacy 132
5.7.3 Vietnam Public Health Association 132
5.8 Trade Fairs 133
6 Opportunities and Challenges 134
6.1 Opportunities 134
6.2 Challenges 134
7 Appendix 136
7.1 Abbreviations 136
7.2 Bibliography 138
7.3 Research Methodology 144
7.3.1 Coverage 145
7.3.2 Secondary Research 145
7.3.3 Forecasts 146
7.3.4 Expert Panel 146
7.4 Disclaimer 146

1.1 List of Tables
Table 1: Pharmaceutical Market, Vietnam, Revenue ($bn), 2008-2015 18
Table 2: Pharmaceutical Market, Vietnam, Revenue Forecast ($bn), 2016-2020 18
Table 3: Pharmaceutical Market, Vietnam, Exports and Imports ($m), 2008-2015 19
Table 4: Pharmaceutical Market, Vietnam, Generic Market Revenue ($bn), 2008-2015 22
Table 5: OTC Market, Vietnam, Revenue ($m), 2008-2015 23
Table 6: Pharmaceutical Market, Vietnam, Major Disease Areas, Prevalence and Number of Mental Disorder Cases, 2005 26
Table 7: Pharmaceutical Market, Sanofi, Major Products, 2015 28
Table 8: Pharmaceutical Market, Sanofi, Global, Late-Stage Pipeline, 2016 29
Table 9: Pharmaceutical Market, DHG Pharmaceutical, Major Products, 2015 35
Table 10: Pharmaceutical Market, Traphaco, Major Products, 2015 37
Table 11: Pharmaceutical Market, Domesco, Major Products, 2015 43
Table 12: Medical Device Market, Vietnam, Revenue ($m), 2008-2015 46
Table 13: Medical Device Market, Vietnam, Revenue ($m), 2016-2020 46
Table 14: Market Access, Vietnam, Health Insurance Population Coverage (%), 2008-2015 53
Table 15: Market Access, Vietnam, Out-of-Pocket Expenditure (%), 2008-2015 54
Table 16: Market Access, Vietnam, Change in Average Price of Healthcare Services (%), 2008-2015 55
Table 17: Regulatory Landscape, Vietnam, Trademark Filing Fees and Charges, 2015 69
Table 18: Regulatory Landscape, Vietnam, Labeling Guidelines, 2015 76
Table 19: Economic Indicators, Vietnam, GDP per Capita ($), 2008-2015 83
Table 20: Economic Indicators, Vietnam, GDP per Capita Forecast ($), 2016-2020 84
Table 21: Economic Indicators, Vietnam, GDP Annual Growth (%), 2008-2015 85
Table 22: Economic Indicators, Vietnam, GDP Annual Growth (%), 2016-2020 86
Table 23: Economic Indicators, Vietnam, GNI Per Capita ($), 2008-2015 87
Table 24: Economic Indicators, Vietnam, Consumer Price Index, 2008-2015 88
Table 25: Economic Indicators, Vietnam, Consumer Price Index, 2016-2020 89
Table 26: Economic Indicators, Vietnam, Consumer Price Annual Change (%), 2008-2015 90
Table 27: Economic Indicators, Vietnam Currency Exchange Rate ($/VND) 2008-2015 91
Table 28: Economic Indicators, Vietnam, FDI ($bn), 2008-2015 92
Table 29: Economic Indicators, Vietnam, Foreign Exchange Reserves ($bn), 2008-2015 93
Table 30: Economic Indicators, Vietnam, Imports of Goods and Services ($bn), 2008-2015 94
Table 31: Economic Indicators, Vietnam, Exports of Goods and Services ($bn), 2008-2015 95
Table 32: Economic Indicators, Vietnam, Government Structural Balance ($bn), 2008-2015 96
Table 33: Economic Indicators, Vietnam, General Government Net Debt ($bn), 2008-2015 97
Table 34: Economic Indicators, Vietnam, General Government Net Debt Forecast ($bn), 2016-2020 98
Table 35: Economic Indicators, Vietnam, Major Industries, Population Employed (million), 2014 99
Table 36: Demographics, Vietnam, Population (million), 2008-2015 100
Table 37: Demographics, Vietnam, Population (million), 2016-2020 101
Table 38: Demographics, Vietnam, Population, Urban and Rural Population Share (%), 2008-2015 102
Table 39: Demographics, Vietnam, Population, Urban and Rural Population Share Forecast (%), 2016-2020 103
Table 40: Demographics, Vietnam, Population Distribution by Age Group (%), 2008-2015 104
Table 41: Demographics, Vietnam, Population Distribution by Age Group Forecast (%), 2016-2020 105
Table 42: Demographics, Vietnam, Births (per 1,000 population), 2008-2015 106
Table 43: Demographics, Vietnam, Mortality (per 1,000 population), 2008-2015 107
Table 44: Demographics, Vietnam, Major Causes of Mortality, Number of Deaths (%), 2011 108
Table 45: Demographics, Vietnam, Children under Five, Mortality Rate (per 1,000 live births), 2008-2015 109
Table 46: Demographics, Vietnam, Immunization Rate (%), 2008-2013 110
Table 47: Demographics, Vietnam, Major Causes of Male Mortality, Number of Cases (‘000), 2011 111
Table 48: Demographics, Vietnam, Major Causes of Female Mortality (‘000), 2011 112
Table 49: Demographics, Vietnam, Gender Ratio (M/F), 2008-2015 113
Table 50: Demographics, Vietnam, Life Expectancy at Birth (years), 2008-2015 114
Table 51: Demographics, Vietnam, Gross Enrollment by Level of Education (%), 2008-2015 115
Table 52: Demographics, Vietnam, Unemployment Rate (%), 2008-2015 116
Table 53: Demographics, Vietnam, Number of Deaths by Disease (‘000), 2013 117
Table 54: Demographics, Vietnam, Major Diseases, DALYs (‘000), 2012 119
Table 55: Healthcare Infrastructure, Vietnam, Health Establishments, 2008-2015 120
Table 56: Healthcare Infrastructure, Vietnam, Number of Beds by Type of Establishment, 2008-2015 121
Table 57: Healthcare Infrastructure, Vietnam, Hospital Beds (per 1,000 population), 2008-2015 122
Table 58: Healthcare Infrastructure, Vietnam, Doctors (per 1,000 population), 2008-2015 123
Table 59: Healthcare Infrastructure, Vietnam, PM2.5 (µg/m3), 2008-2015 124
Table 60: Healthcare Infrastructure, Vietnam, CO2 Emissions (metric tons per capita), 2008-2015 125
Table 61: Healthcare Infrastructure, Vietnam, Nurses (per 1,000 population), 2008-2015 126
Table 62: Healthcare Infrastructure, Vietnam, Midwives (per 1,000 population), 2008-2015 127
Table 63: Healthcare Infrastructure, Vietnam, Pharmacists (per 1,000 population), 2008-2015 128
Table 64: Healthcare Expenditure, Vietnam, Healthcare Expenditure (% of GDP), 2008-2015 129
Table 65: Healthcare Expenditure, Vietnam, Public Healthcare Expenditure, Share of Major Components (%), 2013 130
Table 66: Healthcare Expenditure, Vietnam, Healthcare Expenditure, Public-Private Share (%), 2008-2015 131
Table 67: Healthcare Expenditure, Vietnam, Major Healthcare Trade Fairs, 2016 133

1.2 List of Figures
Figure 1: Pharmaceutical Market, Vietnam, Revenue ($bn), 2008-2015 17
Figure 2: Pharmaceutical Market, Vietnam, Revenue Forecast ($bn), 2016-2020 18
Figure 3: Pharmaceutical Market, Vietnam, Exports and Imports ($m), 2008-2015 19
Figure 4: Pharmaceutical Market, Vietnam, Supply Chain, 2015 20
Figure 5: Pharmaceutical Market, Vietnam, Distribution channels, 2015 21
Figure 6: Pharmaceutical Market, Vietnam, Generic Market Revenue ($bn), 2008-2015 22
Figure 7: Pharmaceutical Market, Vietnam, OTC Market Revenue ($bn), 2008-2015 23
Figure 8: Medical Device Market, Vietnam, Revenue ($m), 2008-2015 45
Figure 9: Medical Device Market, Vietnam, Revenue ($m), 2016-2020 46
Figure 10: Healthcare Market, Vietnam, Drivers and Barriers, 2016 48
Figure 11: Market Access, Vietnam, Overview of Healthcare System 50
Figure 12: Market Access, Vietnam, Overview of Healthcare System 52
Figure 13: Market Access, Vietnam, Health Insurance Population Coverage (%), 2008-2015 53
Figure 14: Market Access, Vietnam, Out-of-Pocket Expenditure (%), 2008-2015 54
Figure 15: Market Access, Vietnam, Change in Average Price of Healthcare Services (%), 2008-2015 55
Figure 16: Market Access, Vietnam, Marketing Authorization Procedure, 2015 60
Figure 17: Regulatory Landscape, Vietnam, Generic Drug Approval Process, 2015 62
Figure 18: Market Access, Vietnam, Patent Approval Process, 2014 70
Figure 19: Economic Indicators, Vietnam, GDP per Capita ($), 2008-2015 83
Figure 20: Economic Indicators, Vietnam, GDP per Capita ($), 2016-2020 84
Figure 21: Economic Indicators, Vietnam, GDP Annual Growth (%), 2008-2015 85
Figure 22: Economic Indicators, Vietnam, GDP Annual Growth (%), 2016-2020 86
Figure 23: Economic Indicators, Vietnam, GNI Per Capita ($), 2008-2015 87
Figure 24: Economic Indicators, Vietnam, Consumer Price Index, 2008-2015 88
Figure 25: Economic Indicators, Vietnam, Consumer Price Index, 2016-2020 89
Figure 26: Economic Indicators, Vietnam, Consumer Price Annual Change (%), 2008-2015 90
Figure 27: Economic Indicators, Vietnam, Currency Exchange Rate ($/VND) 2008-2015 91
Figure 28: Economic Indicators, Vietnam, FDI ($bn), 2008-2015 92
Figure 29: Economic Indicators, Vietnam, Foreign Exchange Reserves ($bn), 2008-2015 93
Figure 30: Economic Indicators, Vietnam, Imports of Goods and Services ($bn), 2008-2015 94
Figure 31: Economic Indicators, Vietnam, Exports of Goods and Services ($bn), 2008-2015 95
Figure 32: Economic Indicators, Vietnam, Government Structural Balance ($bn), 2008-2015 96
Figure 33: Economic Indicators, Vietnam, General Government Net Debt ($bn), 2008-2015 97
Figure 34: Economic Indicators, Vietnam, General Government Net Debt ($bn), 2016-2020 98
Figure 35: Economic Indicators, Vietnam, Major Industries, Population Employed (million), 2014 99
Figure 36: Demographics, Vietnam, Population (million), 2008-2015 100
Figure 37: Demographics, Vietnam, Population (million), 2016-2020 101
Figure 38: Demographics, Vietnam, Population, Urban and Rural Population Share (%), 2008-2015 102
Figure 39: Demographics, Vietnam, Population, Urban and Rural Population Share (%), 2016-2020 103
Figure 40: Demographics, Vietnam, Population Distribution by Age Group (%), 2008-2015 104
Figure 41: Demographics, Vietnam, Population Distribution by Age Group (%), 2016-2020 105
Figure 42: Demographics, Vietnam, Births (per 1,000 population), 2008-2015 106
Figure 43: Demographics, Vietnam, Mortality (per 1,000 population), 2008-2015 107
Figure 44: Demographics, Vietnam, Major Causes of Mortality, Number of Deaths (%), 2011 108
Figure 45: Demographics, Vietnam, Children under Five, Mortality Rate (per 1,000 live births), 2008-2015 109
Figure 46: Demographics, Vietnam, Immunization Rate (%), 2008-2015 110
Figure 47: Demographics, Vietnam, Major Causes of Male Mortality, Number of Cases (‘000), 2011 111
Figure 48: Demographics, Vietnam, Major Causes of Female Mortality, Number of Cases (‘000), 2011 112
Figure 49: Demographics, Vietnam, Gender Ratio (M/F), 2008-2015 113
Figure 50: Demographics, Vietnam, Life Expectancy at Birth (years), 2008-2015 114
Figure 51: Demographics, Vietnam, Gross Enrollment by Level of Education (%), 2008-2015 115
Figure 52: Demographics, Vietnam, Unemployment Rate (%), 2008-2015 116
Figure 53: Demographics, Vietnam, Number of Cases by Disease (‘000), 2012 117
Figure 54: Demographics, Vietnam, Major Diseases, DALYs (‘000), 2012 118
Figure 55: Healthcare Infrastructure, Vietnam, Health Establishments, 2008-2015 120
Figure 56: Healthcare Infrastructure, Vietnam, Number of Beds by Type of Establishment, 2008-2015 121
Figure 57: Healthcare Infrastructure, Vietnam, Hospital Beds (per 1,000 population), 2008-2015 122
Figure 58: Healthcare Infrastructure, Vietnam, Doctors (per 1,000 population), 2008-2015 123
Figure 59: Healthcare Infrastructure, Vietnam, PM2.5 (µg/m3), 2008-2015 124
Figure 60: Healthcare Infrastructure, Vietnam, CO2 Emissions (metric tons per capita), 2008-2015 125
Figure 61: Healthcare Infrastructure, Vietnam, Nurses (per 1,000 population), 2008-2015 126
Figure 62: Healthcare Infrastructure, Vietnam, Midwives (per 1,000 population), 2008-2015 127
Figure 63: Healthcare Infrastructure, Vietnam, Pharmacists (per 1,000 population), 2008-2015 128
Figure 64: Healthcare Expenditure, Vietnam, Healthcare Expenditure (% of GDP), 2008-2015 129
Figure 65: Healthcare Expenditure, Vietnam, Public Healthcare Expenditure, Share of Major Components (%), 2013 130
Figure 66: Healthcare Expenditure, Vietnam, Public-Private Share of Healthcare Expenditure (%), 2008-2015 131
Figure 67: Healthcare Market, Vietnam, Opportunities and Challenges, 2016 135

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-El ...

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro- ...

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.